Extracellular dopamine, norepinephrine, and serotonin in the nucleus accumbens of freely moving rats during intracerebral dialysis with cocaine and other monoamine uptake blockers

Journal of Neurochemistry

Volumn 66, Issue 2, 1996, Pages 559-568

  Li, Ming Ya ^a   Yan, Qing Shan ^a   Coffey, Lori L ^a   Reith, Maarten E A ^a  

^a UNIVERSITY OF ILLINOIS   (United States)

Author keywords

Cocaine; Dopamine; Microdialysis; Norepinephrine; Nucleus accumbens; Serotonin

Indexed keywords

1 [2 (BENZHYDRYLOXY)ETHYL] 4 (3 PHENYLPROPYL)PIPERAZINE; COCAINE; DESIPRAMINE; FLUOXETINE; NISOXETINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; DATA ANALYSIS; DOPAMINE BLOOD LEVEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MICRODIALYSIS; MONOAMINERGIC SYSTEM; NONHUMAN; NORADRENALIN BLOOD LEVEL; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT; SEROTONIN BLOOD LEVEL;

ANIMALIA;

EID: 0030039564     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1996.66020559.x     Document Type: Article

References (61)

1. 3H]GBR 12935 binding in vitro to rat striatal membranes: labeling of the dopamine uptake complex. J. Neurochem 48, 1887-1896.
2. Benloucif S., Keegan M. J., and Galloway M. P. (1993) Serotonin-facilitated dopamine release in vivo. pharmacological characterization. J. Pharmacol. Exp. Ther. 265, 373-377.
3. Benuck M. and Reith M. E. A. (1992) Dopamine releasing effect of phenylbiguanide in rat striatal slices. Naunyn Schmiedebergs Arch. Pharmacol. 345, 666-672.
4. Bobillier P., Seguin S., Petitjean F., Salvert D., Touret M., and Jouvet M. (1976) The raphne nuclei of the cat brain stem: a topographical atlas of their efferent projections as revealed by autoradiography. Brain Res. 113, 449-486.
5. Carboni E., Tanda G. L., Frau R., and Di Chiara G. (1990) Blockade of the noradrenaline carrier increases extracellular dopamine concentrations in the prefrontal cortex: evidence that dopamine is taken up in vivo by noradrenergic terminals. J. Neurochem. 55, 1067-1070.
6. 3 receptor by 1-phenylbiguanide increases dopamine release in the rat nucleus accumbens. Brain Res. 543, 354-357.
7. 3H]-serotonin release in vitro induced by electrical stimulation in A9 and A10 dopamine regions of rat brain: characterization and responsiveness to cocaine. J. Pharmacol. Exp. Ther. 267, 379-389.
8. Chen N.-H. and Reith M. E. A. (1994a) Effects of locally applied cocaine, lidocaine, and various uptake blockers on monoamine transmission in the ventral tegmental area of freely moving rats: a microdialysis study on monoamine interrelationships. J. Neurochem. 63, 1701-1713.
9. Chen N.-H. and Reith M. E. A. (1994b) Autoregulation and monoamine interactions in the ventral tegmental area in the absence and presence of cocaine: a microdialysis study in freely moving rats. J. Pharmacol Exp. Ther. 271, 1597-1610.
10. 3H]WIN 35,428 [2β-carbomethoxy-3β-(4-fluorophenyl)tropane] binding to rat brain membranes: comparing dopamine cell body areas with nerve terminal regions. Biochem. Pharmacol. (in press).
11. Cheramy A., Leviel V., and Glowinski J. (1981) Dendritic release of dopamine in the substantia nigra. Nature 289, 537-542.
12. 3H] Paroxetine binding and serotonin content of rat and rabbit cortical areas, hippocampus, neostriatum, ventral mesencephalic tegmentum, and midbrain raphe nuclei region. Synapse 9, 14-26.
13. 3H]mazindol autoradiography. Brain Res. 504, 64-71.
14. Ennis C., Kemp J. D., and Cox B. (1981) Characterisation of inhibitory 5-hydroxytryptamine receptors that modulate dopamine release in the striatum. J. Neurochem. 36, 1515-1520.
15. Fibiger H. C., Phillips A. G., and Brown E E (1992) The neurobiology of cocaine-induced reinforcement, in Cocaine: Scientific and Social Dimension, Proceedings of the Ciba Foundation Symposium 166, London, 20-22 July 1991 (Bock G. and Whelan J., eds), pp. 96-125. John Wiley, New York.
16. 3H]tomoxetine, an enantiomerically pure ligand for norepinephrine reuptake sites. Neurosci. Lett. 157, 203-206.
17. Grenhoff J. and Svensson T. H. (1993) Prazosin modulates the firing pattern of dopamine neurons in rat ventral tegmental area. Eur. J. Pharmacol. 233, 79-84.
18. Heimer L., Zahm D. S., Churchill L., Kalivas P. W., and Wohltman C. (1991) Specificity in the projection pattern of accumbal core and shell in the rat. Neuroscience 41, 89-125.
19. Hernandez L., Guzman N. A., and Hoebel B. G. (1991) Bidirectional microdialysis in vivo shows differential dopaminergic potency of cocaine, procaine and lidocaine in the nucleus accumbens using capillary electrophoresis for calibration of drug outward diffusion. Psychopharmacology 105, 264-268.
20. 3H] imipramine localization and relationship to serotonin transporter. J. Pharmacol. Exp. Ther. 252, 410-418.
21. Imai H., Steindler D. A., and Kitai S. T. (1986) The organization of divergent axonal projections from the midbrain raphe nuclei in the rat. J. Comp. Neurol. 243, 363-380.
22. 3H]mazindol autoradiography. J. Neurosci. 5, 1513-1521.
23. 3 receptor agonist 2-methylserotonin on the release of dopamine in the nucleus accumbens: an in vivo chronocoulometric study. Brain Res. 513, 156-160.
24. 1A receptors mediate inhibition of tyrosine hydroxylation in rat striatum. J. Pharmacol. Exp. Ther. 266, 133-141.
25. Kalivas P. W. and Duffy P. (1991) A comparison of axonal and somatodendritic dopamine release using in vivo dialysis. J. Neurochem. 56, 961-967.
26. Kalivas P. W. and Stewart J. (1991) Dopamine transmission in the initiation and expression of drug- and stress-induced sensitization of motor activity. Brain Res. Rev. 16, 223-244.
27. 3H]-dopamine is taken up and released from nondopaminergic nerve terminals in the rat substantia nigra in vitro. J. Neurochem. 45, 137-144.
28. Kihara T. and Masato I. (1995) Effects of duloxetine, a new serotonin and norepinephrine uptake inhibitor, on extracellular monoamine levels in rat frontal cortex. J. Pharmacol. Exp. Ther. 272, 177-183.
29. Lategan A. J., Marien M. R., and Colpaert F. C. (1992) Suppression of nigrostriatal and mesolimbic dopamine release in vivo following noradrenaline depletion by DSP-4: a microdialysis study. Life Sci. 50, 995-999.
30. Lichtensteiger W., Mutzner U., and Langemann H. (1967) Uptake of 5-hydroxytryptamine and 5-hydroxytryptophan by neurons of the central nervous system normally containing catecholamines. J. Neurochem. 14, 489-497.
31. Marien M., Lategan A., and Colpaert F. (1994) Noradrenergic control of sttiatal dopamine release, in Noradrenergic Mechanisms in Parkinson's Disease (Briley M. and Marien M., eds), pp. 139-158. CRC Press, Boca Raton, Florida.
32. Marshall J. F., O'Dell S. J., Navarrete R., and Rosenstein A. J. ( 1990) Dopamine high-affinity transport site topography in rat brain: major differences between dorsal and ventral striatum. Neuropharmacology 37, 11-21.
33. 3H-GBR 12935. J. Neural Transm. 87, 1-14.
34. 2-adrenoceptors on 5-hydroxytryptamine terminals in the rat hippocampus. Naunyn Schmiedebergs Arch. Pharmacol. 347, 266-272.
35. Nestler E. (1992) Molecular mechanisms of drug addiction. J. Neurosci. 12, 2439-2450.
36. Nissbrandt H., Pileblad E., and Carlsson A. (1985) Evidence for dopamine release and metabolism beyond the control of nerve impulses and dopamine receptors in rat substantia nigra. J. Pharm. Pharmacol. 37, 884-889.
37. 3H]dopamine release from rat nucleus accumbens slices. Brain Res. 334, 235-242.
38. Pacholczyk T., Blakely R. D., and Amara S. G. (1991) Expression cloning of a cocaine- and antidepressant-sensitive human noradrenaline transporter. Nature 350, 350-354
39. 3H]5-hydroxytryptamine. Neuroscience 6, 115-138.
40. Parsons L. H. and Justice J. B. Jr. (1993) Perfusate serotonin increases extracellular dopamine in the nucleus accumbens as measured by in vivo microdialysis. Brain Res. 606, 195-199.
41. Paxinos G. and Watson C. (1986) The Rat Brain in Stereotaxic Coordinates. Academic Press, New York.
42. 3H] WIN 35,428 binding to dopamine uptake sites in vivo more rapidly than mazindol or GBR 12909. Eur. J. Pharmacol. 198, 203-205.
43. Ramamoorthy S., Bauman A. L., Moore K. R., Han H., Yang-Feng T., Chang A. S., Ganapathy V., and Blakely R. D. (1993) Antidepressant- and cocaine-sensitive human serotonin transporter: molecular cloning, expression, and chromosomal localization. Proc. Natl. Acad. Sci. USA 90, 2542-2546.
44. Reith M. E. A., Meisler B. E., Sershen H., and Lajtha A. (1986) Structural requirements for cocaine congeners to interact with dopamine and serotonin uptake sites in mouse brain and to induce stereotyped behavior. Biochem. Pharmacol. 35, 1123-1129.
45. Reith M. E. A., Coffey L. L., Xu C., and Chen N.-H. (1994) GBR 12909 and 12935 block dopamine uptake into brain synaptic vesicles as well as nerve endings. Eur. J. Pharmacol. 253, 175-178.
46. Richelson E. and Pfenning M. (1984) Blockade by antidepressants and related compounds of biogenic amine uptake into rat brain synaptosomes: most antidepressants selectively block norepinephrine uptake. Eur. J. Pharmacol. 104, 277-286.
47. Ritz M. C., Conoe E. J., and Kuhar M. J. (1990) Cocaine inhibition of ligand binding at dopamine, norepinephrine and serotonin transporters: a structure-activity study. Life Sci. 46, 635-645.
48. Ritz M. C., Lamb R. J., Goldberg S. R., and Kuhar M. J. (1987) Cocaine receptors on dopamine transporters are related to self-administration of cocaine. Science 237, 1219-1223
49. Robertson G. S., Damsma G., and Fibiger H. C. (1991) Characterization of dopamine release in the substantia nigra by in vivo microdialysis in freely moving rats. J. Neurosci. 11, 2209-2216.
50. Rothman R. B., Lewis B., Dersch C., Xu H., Radesca L., De Costa B. R., Rice K. C., Kilburn R. B., Akunne H., and Pert A. (1993) Identification of a GBR12935 homolog, LR1111, which is over 4,000-fold selective for the dopamine transporter, relative to serotonin and norepinephrine transporters. Synapse 14, 34-39
51. Santiago M. and Westerink B. H. C. (1991) Characterization and pharmacological responsiveness of dopamine release recorded by microdialysis in the substantia nigra of conscious rats. J. Neurochem. 57, 738-747.
52. Shank R. P., Gardocki J. F., Schneider C. R., Vaught J. L., Setler P. E., Maryanoff B. E., and McComsey D. F. (1987) Preclinical evaluation of McN-5707 as a potential antidepressant. J. Pharmacol. Exp. Ther. 242, 74-84.
53. Shank R. P., Vaught J. L., Pelley K. A., Setler P. E., McComsey D. F., and Maryanoff B. E. (1988) McN-5652: a highly potent inhibitor of serotonin uptake. J. Pharmacol. Exp. Ther 247, 1032-1038.
54. Shaskan E. G. and Snyder S. H, (1970) Kinetics of serotonin accumulation into slices from rat brain: relationship to catecholamine uptake. J. Pharmacol. Exp. Ther. 175, 404-418.
55. Shimada S., Kitayama S., Lin C. L., Patel A., Nanthakumar E., Gregor P., Kuhar M., and Uhl G. (1991) Cloning and expression of a cocaine-sensitive dopamine transporter complementary DNA. Science 254, 576-578.
56. 2-Adrenoceptor modulation of rat ventral hippocampal 5-hydroxytryptamine release in vivo. Naunyn Schmiedebergs Arch. Pharmacol. 345, 137-143.
57. 2-autoreceptors. Naunyn Schmeidebergs Arch. Pharmacol. 349, 25-33.
58. Westerink B. H. C., Tuntler J., Damsma G., Rollema H., and de Vries J. B. (1987) The use of tetrodotoxin for the characterization of drug-enhanced dopamine release in conscious rats studied by brain dialysis. Naunyn Schmiedebergs Arch. Pharmacol. 336, 502-507.
59. 3H]dopamine by serotonin from superfused rat striatal slices. Neurosci. Lett. 28, 205-209.
60. Yadid G., Pacak K., Kopin I. J., and Goldstein D. S. (1994) Endogenous serotonin stimulates striatal dopamine release in conscious rats. J. Pharmacol. Exp. Ther. 270, 1158-1165.
61. 3H]dopamine release from rat striatal synaptosomes. Eur. J. Pharmacol. 199, 185-189.